Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) March 4, 2023checkorphan Learn more about: Optic pathway glioma Related Clinical Trial Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas Recruitment InformationAdministrative Informations
